Home › NDC Lookup › RxCUI directory › RxCUI 2387347

68 ML brexucabtagene autoleucel 2940000 CELLS/ML Injection — RxCUI 2387347

RxNorm drug concept · Semantic clinical drug
RxCUI 2387347 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2387347
Official name68 ML brexucabtagene autoleucel 2940000 CELLS/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbrexucabtagene autoleucel 200,000,000 CELLS per 68 ML Injection; brexucabtagene autoleucel 200,000,000 CELLS in 68 ML Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Brexucabtagene Autoleucel Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tecartus is not a traditional chemotherapy drug. It's made from your own immune cells — specifically T cells collected from your blood — which are sent to a lab and genetically rep...
  • What exactly is Tecartus and how is it different from regular chemotherapy?
  • Fever is extremely common — nearly everyone gets it — and it's often one of the first signs of your immune system responding. You may also experience chills, low blood pressure, lo...
  • What side effects should I actually expect after the infusion?
📖 Read our full Brexucabtagene Autoleucel Injection guide →

🕸️ Concept Web — How 68 ML brexucabtagene autoleucel 2940000 CELLS/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 68 ML brexucabtagene autoleucel 2940000 CELLS/ML Injection RxCUI 2387347

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Brexucabtagene autoleucel 2387277
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tecartus 2387348
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brexucabtagene autoleucel Injection 2387346
    • Brexucabtagene autoleucel Injectable Product 2387345
    • Brexucabtagene autoleucel Injection [Tecartus] 2387350
    • Tecartus Injectable Product 2387351
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Brexucabtagene autoleucel 2940000 CELLS/ML SCDC · 2387344
  • Brexucabtagene autoleucel Injection SCDF · 2387346
  • Brexucabtagene autoleucel Injectable Product SCDG · 2387345

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2387347 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71287-0219-02 1 BAG in 1 PACKAGE (71287-219-02) / 68 mL in 1 BAG (71287-2... TECARTUS Kite Pharma, Inc. 2020-07-24
71287-0220-02 1 BAG in 1 PACKAGE (71287-220-02) / 68 mL in 1 BAG (71287-2... TECARTUS Kite Pharma, Inc. 2021-10-01
Observed labelers: Kite Pharma, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.